Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral supplementation of two different doses of vitamin D2 (ergocalciferol) in stable preterm infants below 34 weeks gestational age
TCTR20230929004Phase 1Unknown
- Sponsor
- Children's Hospital Foundation
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by Children's Hospital Foundation. Status: unknown.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on TCTR20230929004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230929004.